A348080 Share Price Performance
₩931.00
-51.00 (-5.19%)
Price ₩931.00
Share Price₩931.00
A348080 Community Narratives
There are no narratives available yet.
Recent A348080 News & Updates
No updates
Quratis Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -326.67
- Gross Margin
- -430.33%
- Net Profit Margin
- -1,591.74%
- Debt/Equity Ratio
- 78.1%
Quratis Inc. Competitors
About A348080
- Founded
- 2016
- Employees
- n/a
- CEO
- WebsiteView website
Quratis Inc. engages in developing vaccines in South Korea. It is involved in developing QTP101, a vaccine for tuberculosis; dendritic cell-based cell therapy for indications, including cancer, autoimmune, and infectious diseases; and peptide nucleic acid-based antimicrobial agents. The company also offers drugs contract development and manufacturing services. Quratis Inc. was founded in 2016 and is based in Seoul, South Korea.
South Korean Market Performance
- 7 Days: 3.2%
- 3 Months: 22.8%
- 1 Year: 20.7%
- Year to Date: 31.3%
In the last week, the market has stayed flat, however the Utilities sector stood out, gaining 6.3%. Meanwhile, the market is actually up 23% over the past year. Earnings are forecast to grow by 22% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading